114. Non-dystrophic myotonia syndrome
10 clinical trials, 14 drugs (DrugBank: 5 drugs), 18 drug target genes, 10 drug target pathways
Searched query = "Non-dystrophic myotonia syndrome", "Non-dystrophic Myotonia", "Myotonia congenita", "Thomsen disease", "Becker disease", "Paramyotonia congenita", "Sodium channel myotonia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00004802 (ClinicalTrials.gov) | June 1992 | 24/2/2000 | Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders | Paralysis, Hyperkalemic Periodic;Hypokalemic Periodic Paralysis;Paramyotonia Congenita | Drug: dichlorphenamide | National Center for Research Resources (NCRR) | Ohio State University | Completed | 10 Years | 75 Years | Both | 64 | Phase 3 | NULL |